This TRAN1 award helped to fund the development of Siren Biotechnology’s lead therapy, SRN-101, for high-grade glioma brain cancers in patients. In this reporting period, we completed the final ...

Research Objective Functional restoration following spinal cord injury using defined excitatory and inhibitory spinal interneuron progenitor cell transplantation Impact The development of a stem cell ...

UC Davis scientists win $7 million in California stem cell research grants ...

Tissue-selective chemoattractants direct lymphocytes to epithelial surfaces to establish local immune environments, regulate immune responses to food antigens and commensal organisms, and protect from ...